Uncover Your Pharmaceutical Value |info@vaultbio.com
LinkedInFacebookYouTubeInstagram

Pharma Industry News Weekly Recap: September 22, 2023

2023-09-22T06:48:06-07:004IR, AI, Biden, Breast Cancer, Cancer, Cell Therapy, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Industry News, Insulin, Machine Learning, Obesity, Politics, Research, San Diego Biotech, Vaccines, Women's Health|

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / [...]

Read More

Pharma Industry News Weekly Recap: September 15, 2023

2023-09-15T06:05:28-07:003D Printing, 4IR, AI, Alzheimer's, Biden, Breast Cancer, Cancer, Cell Therapy, COVID-19, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Industry News, Machine Learning, Obesity, Politics, Research, San Diego Biotech, Vaccines, Women's Health|

// Biotech and Pharma Therapeutics AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology September [...]

Read More

Pharma Industry News Weekly Recap: August 25, 2023

2023-08-25T13:33:30-07:004IR, AI, Alzheimer's, Biden, Cancer, Cardiovascular, COVID-19, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Machine Learning, Politics, Private Equity & Venture Capital, Regulatory, Research, Vaccines, Wearables, Women's Health|

// Biotech and Pharma Therapeutics Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans August [...]

Read More

Pharma Industry News Weekly Recap: June 23, 2023

2023-06-23T09:18:57-07:004IR, adipose, AI, Alzheimer's, Biden, Cell Therapy, Chronic Kidney Disease, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Industry News, Insulin, Machine Learning, Mergers, Obesity, Oncology, Politics, Regulatory, Research, San Diego Biotech, Vaccines, Wearables, Women's Health|

// Biotech and Pharma Therapeutics Eli Lilly's Mounjaro is primed to overtake Novo Nordisk's popular diabetes and obesity [...]

Read More
Go to Top